CORESTEM Inc
CORESTEMCHEMON Inc., a bio-pharmaceutical company, engages in the development and production of stem cell therapies for the treatment of incurable diseases in South Korea. It offers NEURONATA-R inj, an autologous bone marrow mesenchymal stem cell therapy for the treatment of amyotrophic lateral sclerosis (ALS). The company also engages in the development of various therapy products for the treatm… Read more
CORESTEM Inc (166480) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -0.103x
Based on the latest financial reports, CORESTEM Inc (166480) has a cash flow conversion efficiency ratio of -0.103x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-4.18 Billion) by net assets (₩40.62 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
CORESTEM Inc - Cash Flow Conversion Efficiency Trend (2014–2024)
This chart illustrates how CORESTEM Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
CORESTEM Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of CORESTEM Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Readytech Holdings Ltd
AU:RDY
|
0.039x |
|
M.I.TECH Co.Ltd
KQ:179290
|
0.047x |
|
MS Autotech Co.Ltd
KQ:123040
|
0.163x |
|
Pioneer Credit Ltd
AU:PNC
|
0.010x |
|
KOTON MAGAZACILIK
IS:KOTON
|
0.102x |
|
Comtec Sys
KO:031820
|
-0.007x |
|
PRICELINE.COM
BE:PCE1
|
-0.650x |
|
Top Frontier Investment Holdings Inc
OTCGREY:TPHIF
|
0.060x |
Annual Cash Flow Conversion Efficiency for CORESTEM Inc (2014–2024)
The table below shows the annual cash flow conversion efficiency of CORESTEM Inc from 2014 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩48.59 Billion | ₩-21.12 Billion | -0.435x | +45.73% |
| 2023-12-31 | ₩19.60 Billion | ₩-15.70 Billion | -0.801x | -294.34% |
| 2022-12-31 | ₩41.46 Billion | ₩-8.42 Billion | -0.203x | +1.23% |
| 2021-12-31 | ₩37.19 Billion | ₩-7.65 Billion | -0.206x | -290.05% |
| 2020-12-31 | ₩41.29 Billion | ₩4.47 Billion | 0.108x | +1260.00% |
| 2019-12-31 | ₩57.70 Billion | ₩-538.08 Million | -0.009x | +48.55% |
| 2018-12-31 | ₩62.24 Billion | ₩-1.13 Billion | -0.018x | +81.10% |
| 2017-12-31 | ₩65.60 Billion | ₩-6.29 Billion | -0.096x | -282.69% |
| 2016-12-31 | ₩66.73 Billion | ₩3.50 Billion | 0.053x | +424.60% |
| 2015-12-31 | ₩63.04 Billion | ₩-1.02 Billion | -0.016x | +87.47% |
| 2014-12-31 | ₩18.97 Billion | ₩-2.45 Billion | -0.129x | -- |